Choosing therapy on the basis of disease classifications in inflammatory bowel disease

  • Maria T. Abreu

DOI: 10.1007/s11938-004-0038-9

Cite this article as:
Abreu, M.T. Curr Treat Options Gastro (2004) 7: 169. doi:10.1007/s11938-004-0038-9

Opinion statement

Crohn’s disease and ulcerative colitis (UC) are heterogeneous disorders, and as such, the response to therapy is likewise heterogeneous. Therefore, stratification of patients into distinct phenotypes and potentially genotypes will lead to more definitive answers with respect to evaluation of novel and established therapies.

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • Maria T. Abreu
    • 1
  1. 1.Inflammatory Bowel Disease Center, Cedars-Sinai Medical CenterLos AngelesUSA

Personalised recommendations